Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 15Carcinoma, Hepatocellular 9Stomach Neoplasms 8Rectal Neoplasms 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Brain Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Recurrence 4Urinary Bladder Neoplasms 3Pilonidal Sinus 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Melanoma 3Lung Neoplasms 3Kidney Neoplasms 3Glioblastoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Pain, Postoperative 2Pain 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Liver Neoplasms 2Gastrointestinal Stromal Tumors 2

Interventions

Proton Therapy 2Propofol 2Hydrocortisone 2Desflurane 2parecoxib 1loxoprofen 1Yoga 1Transcranial Magnetic Stimulation 1Tramadol 1Surgical Procedures, Operative 1Supine Position 1Sevoflurane 1Saline Solution 1Rosiglitazone 1Resistance Training 1Radiation Dose Hypofractionation 1Protons 1Positron-Emission Tomography 1Octreotide 1Neurosurgical Procedures 1Neuropsychological Tests 1Nasal Lavage 1Human Growth Hormone 1Endoscopic Mucosal Resection 1Early Intervention, Educational 1Dexamethasone 1Deamino Arginine Vasopressin 1Cabergoline 1Bromocriptine 1Bed Rest 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pituitary Neoplasms × Surgical Procedures, Operative × Clear all
NCT03714763 2018-10-22

Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)

Ruijin Hospital

Phase NA Unknown
50 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡